Ketovite tablets
- Name:
Ketovite tablets
- Company:
Essential Pharmaceuticals Ltd
- Active Ingredients:
- Legal Category:
Supply through pharmacy only
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 12/10/20

Summary of Product Characteristics last updated on medicines.ie: 12/10/2020
Click on this link to Download PDF directly
Essential Pharmaceuticals Ltd

Company Products
Medicine Name | Active Ingredients |
---|---|
Medicine Name Ketovite Liquid | Active Ingredients Multivitamins |
Medicine Name Ketovite tablets | Active Ingredients Multivitamins |
Items Per Page :
1 - 0 of 2 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 12 October 2020 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 12 October 2020 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Updated on 6 January 2020 PIL
Reasons for updating
- New individual PIL (was previously included in a combined PIL)
Updated on 6 January 2020 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
Updated on 27 June 2019
Updated on 12 June 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 12 June 2019 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
Legal category: Supply through pharmacy only
Updated on 22 June 2018 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Addition of Anaphylactic reaction.
Align to QRD.
Updated on 22 June 2018 PIL
Reasons for updating
- Change to side-effects
Updated on 19 June 2015 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through pharmacy only
Updated on 19 June 2015 SPC
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
In section 4.8 (undesirable effects) the statement about how to report side effects has been added:$0$0Reporting ofsuspected adverse reactions: $0$0Reportingsuspected adverse reactions after authorisation of the medicinal product isimportant. It allows continued monitoring of the benefit/risk balance of themedicinal product. Healthcare professionals are asked to report any suspectedadverse reactions via $0$0HPRA Pharmacovigilance $0$0Earlsfort Terrace $0$0IRL - Dublin 2 $0$0Tel: +353 1 6764971 $0$0Fax: +353 1 6762517 $0$0Website: www.hpra.ie $0$0e-mail: medsafety@hpra.ie $0$0
Updated on 17 June 2015 PIL
Reasons for updating
- New PIL for new product
Updated on 17 June 2015 PIL
Reasons for updating
- Addition of information on reporting a side effect.
Updated on 5 October 2012 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
None provided
Updated on 3 October 2012 PIL
Reasons for updating
- New PIL for medicines.ie